Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cell Vaccine for Children and Adults With Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Adjuvant Effect of Chloroquine on Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
BAY86-9766 Plus Gemcitabine Phase I Study in Asian
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
GTX-RT in Borderline Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE3
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2